Profile picture

Doctor Matthias M Engelen

University Hospitals (UZ) Leuven, Leuven (Belgium)
Follow
Biography
After being a young professional athlete, he started med school in 2010. He graduated as a medical doctor in 2017 whereafter he got trained in internal medicine as a junior doctor. His master dissertation looked into the clinical use and consequences of thrombolytic therapy, showing his interest in thrombosis and haemostasis. Just recently, he started working on coagulation in cardiovascular diseases as a PhD researcher.
Logo ESC

Contributor content

Heparin is more effective than apixaban in inhibiting in vitro contact activated coagulation
Presentation
Heparin is more effective than apixaban in inhibiting in vitro contact activated coagulation
Trends in indications and outcome in thrombolytic therapy: a retrospective single center study
Presentation
Trends in indications and outcome in thrombolytic therapy: a retrospective single center study

ESC 365 is supported by